126 related articles for article (PubMed ID: 33275483)
21. Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19.
Rehman MT; AlAjmi MF; Hussain A
Curr Pharm Des; 2021; 27(33):3577-3589. PubMed ID: 33200697
[TBL] [Abstract][Full Text] [Related]
22. RETRACTED: Amentoflavone suppresses hepatocellular carcinoma by repressing hexokinase 2 expression through inhibiting JAK2/STAT3 signaling.
Liu B; Yu S
Biomed Pharmacother; 2018 Nov; 107():243-253. PubMed ID: 30096628
[TBL] [Abstract][Full Text] [Related]
23. RETRACTED: Human Suicide, Modern Diagnosis Assistance and Magic Bullet Discovery.
Lu DY; Zhu PP; Wu HY; Xu B; Lu TR
Cent Nerv Syst Agents Med Chem; 2019; 19(1):15-23. PubMed ID: 30644350
[TBL] [Abstract][Full Text] [Related]
24. Using integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2.
Al-Khafaji K; Al-Duhaidahawi D; Taskin Tok T
J Biomol Struct Dyn; 2021 Jun; 39(9):3387-3395. PubMed ID: 32364041
[TBL] [Abstract][Full Text] [Related]
25. Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery.
Ray AK; Sen Gupta PS; Panda SK; Biswal S; Bhattacharya U; Rana MK
Comput Biol Med; 2022 Mar; 142():105183. PubMed ID: 34986429
[TBL] [Abstract][Full Text] [Related]
26. Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches.
Bhowmik D; Nandi R; Jagadeesan R; Kumar N; Prakash A; Kumar D
Infect Genet Evol; 2020 Oct; 84():104451. PubMed ID: 32640381
[TBL] [Abstract][Full Text] [Related]
27. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
Bimonte S; Crispo A; Amore A; Celentano E; Cuomo A; Cascella M
In Vivo; 2020 Jun; 34(3 Suppl):1597-1602. PubMed ID: 32503817
[TBL] [Abstract][Full Text] [Related]
28. Remdesivir Strongly Binds to Both RNA-Dependent RNA Polymerase and Main Protease of SARS-CoV-2: Evidence from Molecular Simulations.
Nguyen HL; Thai NQ; Truong DT; Li MS
J Phys Chem B; 2020 Dec; 124(50):11337-11348. PubMed ID: 33264025
[TBL] [Abstract][Full Text] [Related]
29. Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2.
Yadav R; Imran M; Dhamija P; Chaurasia DK; Handu S
J Biomol Struct Dyn; 2021 Oct; 39(17):6617-6632. PubMed ID: 32715956
[TBL] [Abstract][Full Text] [Related]
30. RETRACTED: Ankle-hindfoot after calcaneal fractures: A biomechanical study.
Xu C; Li M; Wang C; Li K; Liu H
Orthop Traumatol Surg Res; 2017 Sep; 103(5):709-716. PubMed ID: 28619268
[TBL] [Abstract][Full Text] [Related]
31. RETRACTED: Association Between Polymorphisms in the Interleukin-10 Gene and Susceptibility to HIV-1 Infection.
Fu DH; Deng WJ; Yang Z; Hong S; Ding QL; Zhao Y; Chen J; Su DK
AIDS Res Hum Retroviruses; 2020 Jun; ():. PubMed ID: 32546004
[No Abstract] [Full Text] [Related]
32. Identification of bioactive molecule from
Tripathi MK; Singh P; Sharma S; Singh TP; Ethayathulla AS; Kaur P
J Biomol Struct Dyn; 2021 Sep; 39(15):5668-5681. PubMed ID: 32643552
[TBL] [Abstract][Full Text] [Related]
33. Computational screening of dual inhibitors from FDA approved antiviral drugs on SARS-CoV-2 spike protein and the main protease using molecular docking approach.
Sabarimurugan S; Purushothaman I; Swaminathan R; Dharmarajan A; Warrier S; Kothandan S
Acta Virol; 2021; 65(2):160-172. PubMed ID: 34130467
[TBL] [Abstract][Full Text] [Related]
34. RETRACTED: No deleterious effect of lockdown due to COVID-19 pandemic on glycaemic control, measured by glucose monitoring, in adults with type 1 diabetes.
Beato-Víbora PI
Diabetes Technol Ther; 2020 May; ():. PubMed ID: 32396400
[TBL] [Abstract][Full Text] [Related]
35. RETRACTED: Molecular basis of AMD: current concepts and recent advances.
Anand A; Prabhakar S; Ambeti J
Trends Mol Med; 2005 Jun; ():. PubMed ID: 15963761
[TBL] [Abstract][Full Text] [Related]
36. Retracted: Computational Study on the Inhibitory Effect of Natural Compounds against the SARS-CoV-2 Proteins.
And Applications BC
Bioinorg Chem Appl; 2023; 2023():9804379. PubMed ID: 37829663
[TBL] [Abstract][Full Text] [Related]
37. Retracted: A Bioinformatic Approach Based on Systems Biology to Determine the Effects of SARS-CoV-2 Infection in Patients with Hypertrophic Cardiomyopathy.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9769073. PubMed ID: 38124959
[TBL] [Abstract][Full Text] [Related]
38. Retracted: Measures of Adiposity and Risk of Testing Positive for SARS-CoV-2 in the UK Biobank Study.
Obesity JO
J Obes; 2022; 2022():9848453. PubMed ID: 35342645
[TBL] [Abstract][Full Text] [Related]
39. Correction to "Anti-PD-1 therapy for advanced colorectal cancer based on intestinal microecology" H. Pi, S. Liang, H. Liu, S. Lu, L. Huang, J. Biochem. Mol. Toxicol. 2023, e23438. https://doi.org/10.1002/jbt.23438.
J Biochem Mol Toxicol; 2024 Apr; 38(4):e23701. PubMed ID: 38558224
[No Abstract] [Full Text] [Related]
40. Retracted: A Bioinformatics Approach for the Prediction of Immunogenic Properties and Structure of the SARS-COV-2 B.1.617.1 Variant Spike Protein.
International BR
Biomed Res Int; 2024; 2024():9784929. PubMed ID: 38550125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
